Comments
Loading...

Relmada Therapeutics

RLMDNASDAQ
Logo brought to you by Benzinga Data
$3.30
0.051.54%
At close: -
$3.28
-0.02-0.61%
After Hours: Nov 8, 4:02 PM EDT
Q3 2024 Earnings were released on Thu Nov 7th, after the market close
The most recent conference call was at 16:30 PM, 5 days ago Click to view past webcast

Relmada Therapeutics (NASDAQ:RLMD) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Relmada Therapeutics (RLMD)?

A

There have been no specific sales or earnings guidance reported for Relmada Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch